Sat.Jul 06, 2024

article thumbnail

Opinion: First Opinion readers respond to psychiatry and social contracts, Medicare and weight loss meds, and more

STAT

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.

280
280
article thumbnail

Why India must legalise and regulate hemp products

Express Pharma

The hemp industry in India is expanding rapidly, but there are several obstacles standing in its way. These include strict rules and regulations and a lot of misinformation. The sector can only flourish if the government provides backing in the form of legalisation and awareness campaigns on hemp and its products. Focusing on sustainable development and a defined course of action will establish India as a leader in the global hemp market and encourage ethical practices.

Labelling 119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

China Leads in AI-Driven Drug Discovery Patents, Signaling Pharmaceutical Innovation Boom

Drug Patent Watch

China is emerging as a global frontrunner in patenting artificial intelligence (AI) technologies for drug discovery, particularly in the field […] Source

86
article thumbnail

The Rising Iceberg of Lyophilized Innovations

PharmaTech

The increased demand for biopharmaceutical products is increasing the demand for lyophilization innovations and services.

69
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

59
article thumbnail

The Crucial Role of Pharmaceutical Impurity Reference Standards in Quality Control

Pharma Mirror

Ensuring the safety and efficacy of pharmaceutical products is paramount in the healthcare industry. Pharmaceutical impurity reference standards play a critical role in this process by helping to identify and quantify impurities. Understanding their importance can significantly enhance quality control measures in drug development and production. In today’s pharmaceutical industry, maintaining high-quality standards is not just a regulatory requirement but also an ethical obligation.

More Trending

article thumbnail

Which pharmaceutical companies have the most insert dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most insert dosed drugs. For a different perspective, see the most popular dosage types.

article thumbnail

Data-Driven Development: How Real-World Data and AI Are Transforming Clinical Trials

Pharmacy Times

Real-world data and artificial intelligence (AI) are poised to revolutionize drug development by optimizing clinical trials and regulatory approvals, if data quality and patient privacy challenges are addressed.